Patents by Inventor Sandy Simon

Sandy Simon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B-cell reduction using CD37-specific and CD20-specific binding molecules
    Publication number: 20070059306
    Abstract: The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules. In particular, the invention provides methods for B-cell reduction using CD37-specific binding molecules alone, or a combination of CD37-specific binding molecules and CD20-specific binding molecules, in some instances a synergistic combination. The invention further provides materials and methods for treatment of diseases involving aberrant B-cell activity. In addition, the invention provides humanized CD37-specific binding molecules.
    Type: Application
    Filed: July 25, 2006
    Publication date: March 15, 2007
    Applicant: TRUBION PHARMACEUTICALS, INC.
    Inventors: Laura Grosmaire, Martha Hayden-Ledbetter, Jeffrey Ledbetter, Peter Thompson, Sandy Simon, William Brady